ABSTRACT
BACKGROUND: Stimulation of transient receptor potential ankyrin 1 (TRPA1), which abundantly expressed in enterochromaffin cells (ECC), has been reported to exert apparently contradictory results in in vitro contractility and in vivo gastrointestinal (GI) transit evaluations. The pharmaceutical-grade Japanese traditional medicine daikenchuto (TU-100) has been reported to be beneficial for postoperative ileus (POI) and accelerate GI transit in animals and humans. TU-100 was recently shown to increase intestinal blood flow via stimulation of TRPA1 in the epithelial cells of the small intestine (SI). METHODS: The effects of various TRPA1 agonists on motility were examined in a manipulation-induced murine POI model, in vitro culture of SI segments and an ECC model cell line, RIN-14B. KEY RESULTS: Orally administered TRPA1 agonists, aryl isothiocyanate (AITC) and cinnamaldehyde (CA), TU-100 ingredients, [6]-shogaol (6S) and γ-sanshool (GS), improved SI transit in a POI model. The effects of AITC, 6S and GS but not CA were abrogated in TRPA1-deficient mice. SI segments show periodic peristaltic motor activity whose periodicity disappeared in TRPA1-deficient mice. TU-100 augmented the motility. AITC, CA and 6S increased 5-HT release from isolated SI segments and the effects of all these compounds except for CA were lost in TRPA1-deficient mice. 6S and GS induced a release of 5-HT from RIN-14B cells in a dose- and TRPA1-dependent manner. CONCLUSIONS & INFERENCES: Intraluminal TRPA1 stimulation is a potential therapeutic strategy for GI motility disorders. Further investigation is required to determine whether 5-HT and/or ECC are involved in the effect of TRPA1 on motility.
Subject(s)
Disease Models, Animal , Gastrointestinal Transit/drug effects , Gastrointestinal Transit/physiology , Ileus/drug therapy , TRPA1 Cation Channel/agonists , TRPA1 Cation Channel/physiology , Acrolein/analogs & derivatives , Acrolein/pharmacology , Acrolein/therapeutic use , Amides/pharmacology , Amides/therapeutic use , Animals , Cells, Cultured , Dose-Response Relationship, Drug , Ileus/physiopathology , Male , Mice , Mice, 129 Strain , Mice, Inbred C57BL , Naphthoquinones/pharmacology , Naphthoquinones/therapeutic use , Organ Culture TechniquesABSTRACT
The traditional Japanese medicine rikkunshito ameliorates the nitric oxide-associated delay in gastric emptying. Whether rikkunshito affects gastric motility associated with 5-hydroxytryptamine (serotonin: 5-HT) receptors or dopamine receptors is unknown. We examined the effects of rikkunshito on the delay in gastric emptying induced by 5-HT or dopamine using the phenol red method in male Wistar rats. 5-HT (0.01-1.0 mg kg(-1), i.p.) dose dependently delayed gastric emptying, similar to the effect of the 5-HT(3) receptor agonist 1-(3-chlorophenyl) biguanide (0.01-1.0 mg kg(-1), i.p.). Dopamine also dose dependently delayed gastric emptying. The 5-HT(3) receptor antagonist ondansetron (0.04-4.0 mg kg(-1)) and rikkunshito (125-500 mg kg(-1)) significantly suppressed the delay in gastric emptying caused by 5-HT or 1-(3-chlorophenyl) biguanide. Hesperidin (the most active ingredient in rikkunshito) suppressed the 5-HT-induced delayed gastric emptying in a dose-dependent manner, the maximum effect of which was similar to that of ondansetron (0.4 mg kg(-1)). The improvement obtained by rikkunshito or ondansetron in delaying gastric emptying was completely blocked by pretreatment with atropine. Rikkunshito appears to improve delay in gastric emptying via the antagonistic action of the 5-HT(3) receptor pathway.
ABSTRACT
The RT-PCR method was employed to determine the cytokine mRNA expression of human peripheral lymphocytes induced by the Japanese herbal medicine Sho-saiko-to (TJ-9). The results showed that the mRNA expression of IL-12, IL-1beta, IL-10, TNF-alpha, G-CSF, and IFN-gamma increased after 6 hr in culture. This is the first reported finding that TJ-9 is an IFN-gamma inducer. Next, cytokine mRNA expression was semi-quantitatively measured using the Gel Doc system with a CCD camera and then statistically analyzed in order to determine which component of TJ-9 was the true cytokine inducer. The results showed that the scutellaria root is the main component inducing the cytokines, while the glycyrrhiza root is the secondary component. When the cytokine concentrations in the supernatants of cell cultures were measured by ELISA, the levels of IL-12, IL-1beta, IL-10, TNF-alpha, and G-CSF reflected mRNA expression levels in the cell fraction. However, the level of IFN-gamma was below the detectable limit. The effects of various reagents on many different kinds of cytokine mRNA expression could be analyzed objectively in a short time using the Gel Doc system. Many important findings could be demonstrated by this simple, easy, sensitive, and cheap method. After the clinical significance of cytokine analysis is confirmed, this method may become a useful clinical examination tool.
Subject(s)
Cytokines/genetics , Drugs, Chinese Herbal/pharmacology , Gene Expression/drug effects , RNA, Messenger/analysis , Cells, Cultured , Electrophoresis, Agar Gel , Granulocyte Colony-Stimulating Factor/genetics , Humans , Image Processing, Computer-Assisted , Interferon-gamma/genetics , Interleukin-1/genetics , Interleukin-10/genetics , Interleukin-12/genetics , Plant Extracts , Reverse Transcriptase Polymerase Chain Reaction , Sensitivity and Specificity , Tumor Necrosis Factor-alpha/geneticsABSTRACT
Inchinko-to (TJ-135) is a herbal medicine consisting of three kinds of crude drugs, and in Japan it is administered mainly to patients with cholestasis. The present study evaluated the effects of TJ-135 on concanavalin A (con A)-induced hepatitis in mice in vivo and con A-induced cytokine production in vitro. When mice were pretreated with oral TJ-135 for 1 week before intravenous con A injection, the activities of serum aspartate aminotransferase (AST), alanine aminotransferase (ALT) and lactate dehydrogenase (LDH) were significantly decreased 8 h after con A administration (-82%, -96% and -66% respectively). In histological investigations, sub-massive hepatic necrosis accompanying inflammatory cell infiltration was not observed in mice pretreated with TJ-135. Serum levels of interleukin-12 (IL-12), interferon-gamma (IFN-gamma) and IL-2 were significantly lower in mice pretreated with TJ-135 compared with controls, while IL-10 levels were higher in these mice. Intrasplenic IL-12 levels were significantly lower in mice pretreated with TJ-135, while intrasplenic IL-10 levels were higher in these mice. In vitro, IL-10 production by splenocytes was increased by the addition of TJ-135 to the culture medium, whereas the production of IL-12 and IFN-gamma was inhibited. These results suggest that con A-induced hepatitis was ameliorated by pretreatment with TJ-135. With regard to the mechanism of these effects of TJ-135, we speculate that TJ-135 inhibits the production of inflammatory cytokine and enhances the production of anti-inflammatory cytokines. Therefore administration of TJ-135 may be useful in patients with severe acute hepatitis accompanying cholestasis or in those with autoimmune hepatitis.
Subject(s)
Chemical and Drug Induced Liver Injury/drug therapy , Concanavalin A/toxicity , Plants, Medicinal/physiology , Alanine Transaminase/blood , Alanine Transaminase/drug effects , Animals , Aspartate Aminotransferases/blood , Aspartate Aminotransferases/drug effects , Chemical and Drug Induced Liver Injury/etiology , Disease Models, Animal , Interferon-gamma/blood , Interferon-gamma/drug effects , Interleukin-10/blood , Interleukin-10/physiology , Interleukin-12/blood , Interleukin-12/physiology , Interleukin-2/blood , Interleukin-2/physiology , Japan , L-Lactate Dehydrogenase/blood , L-Lactate Dehydrogenase/drug effects , Male , Medicine, East Asian Traditional , Mice , Mice, Inbred ICR , Plant LectinsABSTRACT
The effects of Sho-seiryu-to, an antiallergic Kampo medicine, on experimental allergic rhinitis were investigated in actively sensitized guinea pigs. The number of sneezes and scratches by the animals after a topical antigen challenge was significantly inhibited by pretreatment with Sho-seiryu-to (1000 mg/kg per os p.o.). The antigen-induced eosinophil infiltration in the nasal mucosa was significantly inhibited by Sho-seiryu-to (1000 mg/kg p.o.). Sho-seiryu-to (100 mg/kg p.o.) also reduced the increase in dye leakage to the nasal cavity induced by the antigen challenge and the antigen-induced decrease in volume of the nasal cavity was inhibited. Moreover, Sho-seiryu-to (1000 mg/kg p.o.) suppressed the volume change in the nasal cavity induced by leukotriene D4. These results demonstrate that Sho-seiryu-to inhibits experimental allergic rhinitis in guinea pigs, confirming that the agent may be beneficial for the treatment of allergic rhinitis.
Subject(s)
Cell Migration Inhibition , Eosinophils/drug effects , Nasal Mucosa/drug effects , Phytotherapy , Plants, Medicinal/therapeutic use , Rhinitis, Allergic, Perennial/drug therapy , Animals , Antigens/adverse effects , Antigens/immunology , Behavior, Animal/drug effects , Coloring Agents/pharmacokinetics , Guinea Pigs , Male , Nasal Mucosa/immunology , Nasal Mucosa/pathology , Plants, Medicinal/immunologyABSTRACT
Examination was made of the pharmacological characteristics of Sho-seiryu-to, an antiallergic kampo medicine. Sho-seiryu-to suppressed histamine release from rat peritoneal mast cells, but failed to inhibit the binding of [3H]-mepyramine to histamine H1 receptors in guinea pig cerebral cortex and lung. Sho-seiryu-to had no effect on cutaneous reactions induced by serotonin, platelet-activating factor (PAF), leukotriene (LT) C4 or LTD4. Ketotifen prolonged electrically induced convulsions, while Sho-seiryu-to did not. Sho-seiryu-to did not affect salivation induced by pilocarpine. Sho-seiryu-to thus does not appear to inhibit histamine H1 receptors or inflammation induced by serotonin, PAF, LTC4 and LTD4, but suppresses mast cell activity. Sho-seiryu-to would thus have only a few side effects such as dry mouth and convulsions due mainly to the blockage of the action of muscarinic in salivary glands and histamine in the brain.
Subject(s)
Drugs, Chinese Herbal/pharmacology , Histamine H1 Antagonists/pharmacology , Animals , Behavior, Animal/drug effects , Cerebral Cortex/metabolism , Guinea Pigs , Histamine Release/immunology , In Vitro Techniques , Lung/metabolism , Male , Mast Cells/immunology , Mast Cells/metabolism , Mice , Peritoneal Cavity/cytology , Pilocarpine/antagonists & inhibitors , Pyrilamine/metabolism , Rats , Rats, Sprague-Dawley , Rats, Wistar , Receptors, Histamine H1/metabolism , Salivation/drug effects , Skin Tests , TritiumABSTRACT
Wen-Qing-Yin, a Chinese blended medicine, is reported to be effective against aphthous stomatitis and ulcus vulvae acutum of Behçet's syndrome, although there are no basic experimental studies supporting its clinical effectiveness. Although pathogenesis of Behçet's syndrome is not known, involvement of cellular immunodeficiency has been suggested. In the present paper, the effect of Wen-Qing-Yin on type IV allergic reactions concerned with cellular immunity, and to a lesser extent, formation of humoral antibodies were investigated. Wen-Qing-Yin did not affect the effector phases of type IV allergic reactions including picryl chloride-induced contact dermatitis and footpad reactions induced by sheep red blood cells and tuberculin in mice. However, the induction phases of all these reactions were significantly inhibited with Wen-Qing-Yin. Local graft vs host reaction induced by lymphocytes of Balb/c mice into the footpads of CBF1 mice, was significantly inhibited with Wen-Qing-Yin. The formation of hemolytic plaque forming spleen cells (IgG-PFC and IgM-PFC) from mice were inhibited or tended to be inhibited with Wen-Qing-Yin. Hemolysin formation in the blood of these animals was inhibited or tended to be inhibited with Wen-Qing-Yin. It is suggested that the therapeutic effect of Wen-Qing-Yin on Behçet's syndrome may be mainly due to an inhibitory action on the early phases of the cellular immune response.